Literature DB >> 19803746

Redox control of prion and disease pathogenesis.

Neena Singh1, Ajay Singh, Dola Das, Maradumane L Mohan.   

Abstract

Imbalance of brain metal homeostasis and associated oxidative stress by redox-active metals like iron and copper is an important trigger of neurotoxicity in several neurodegenerative conditions, including prion disorders. Whereas some reports attribute this to end-stage disease, others provide evidence for specific mechanisms leading to brain metal dyshomeostasis during disease progression. In prion disorders, imbalance of brain-iron homeostasis is observed before end-stage disease and worsens with disease progression, implicating iron-induced oxidative stress in disease pathogenesis. This is an unexpected observation, because the underlying cause of brain pathology in all prion disorders is PrP-scrapie (PrP(Sc)), a beta-sheet-rich conformation of a normal glycoprotein, the prion protein (PrP(C)). Whether brain-iron dyshomeostasis occurs because of gain of toxic function by PrP(Sc) or loss of normal function of PrP(C) remains unclear. In this review, we summarize available evidence suggesting the involvement of oxidative stress in prion-disease pathogenesis. Subsequently, we review the biology of PrP(C) to highlight its possible role in maintaining brain metal homeostasis during health and the contribution of PrP(Sc) in inducing brain metal imbalance with disease progression. Finally, we discuss possible therapeutic avenues directed at restoring brain metal homeostasis and alleviating metal-induced oxidative stress in prion disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19803746      PMCID: PMC2864664          DOI: 10.1089/ars.2009.2628

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  250 in total

1.  Normal prion protein has an activity like that of superoxide dismutase.

Authors:  D R Brown; B S Wong; F Hafiz; C Clive; S J Haswell; I M Jones
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

2.  The octapeptide repeat region of prion protein binds Cu(II) in the redox-inactive state.

Authors:  N Shiraishi; Y Ohta; M Nishikimi
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

3.  The N-terminal tandem repeat region of human prion protein reduces copper: role of tryptophan residues.

Authors:  F H Ruiz; E Silva; N C Inestrosa
Journal:  Biochem Biophys Res Commun       Date:  2000-03-16       Impact factor: 3.575

4.  Transmissible and genetic prion diseases share a common pathway of neurodegeneration.

Authors:  R S Hegde; P Tremblay; D Groth; S J DeArmond; S B Prusiner; V R Lingappa
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

5.  Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice.

Authors:  J I Kim; W K Ju; J H Choi; E Choi; R I Carp; H M Wisniewski; Y S Kim
Journal:  Brain Res Mol Brain Res       Date:  1999-11-10

6.  Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity.

Authors:  A R White; S J Collins; F Maher; M F Jobling; L R Stewart; J M Thyer; K Beyreuther; C L Masters; R Cappai
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  Strain-specific prion-protein conformation determined by metal ions.

Authors:  J D Wadsworth; A F Hill; S Joiner; G S Jackson; A R Clarke; J Collinge
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

8.  Brain copper content and cuproenzyme activity do not vary with prion protein expression level.

Authors:  D J Waggoner; B Drisaldi; T B Bartnikas; R L Casareno; J R Prohaska; J D Gitlin; D A Harris
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

9.  Prion protein expression aids cellular uptake and veratridine-induced release of copper.

Authors:  D R Brown
Journal:  J Neurosci Res       Date:  1999-12-01       Impact factor: 4.164

10.  Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.

Authors:  R M Whittal; H L Ball; F E Cohen; A L Burlingame; S B Prusiner; M A Baldwin
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

View more
  24 in total

1.  The Rich Electrochemistry and Redox Reactions of the Copper Sites in the Cellular Prion Protein.

Authors:  Feimeng Zhou; Glenn L Millhauser
Journal:  Coord Chem Rev       Date:  2012-05-04       Impact factor: 22.315

2.  Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.

Authors:  Elisa Meneghetti; Lisa Gasperini; Tommaso Virgilio; Fabio Moda; Fabrizio Tagliavini; Federico Benetti; Giuseppe Legname
Journal:  Mol Neurobiol       Date:  2019-02-01       Impact factor: 5.590

3.  Copper redox cycling in the prion protein depends critically on binding mode.

Authors:  Lin Liu; Dianlu Jiang; Alex McDonald; Yuanqiang Hao; Glenn L Millhauser; Feimeng Zhou
Journal:  J Am Chem Soc       Date:  2011-07-18       Impact factor: 15.419

4.  Cellular prion protein (PrPC) in the development of Merlin-deficient tumours.

Authors:  L Provenzano; Y Ryan; D A Hilton; J Lyons-Rimmer; F Dave; E A Maze; C L Adams; R Rigby-Jones; S Ammoun; C O Hanemann
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

5.  Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.

Authors:  Ajay Singh; Liuting Qing; Qingzhong Kong; Neena Singh
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

6.  Prion protein regulates iron transport by functioning as a ferrireductase.

Authors:  Ajay Singh; Swati Haldar; Katharine Horback; Cynthia Tom; Lan Zhou; Howard Meyerson; Neena Singh
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.

Authors:  Swati Haldar; 'alim J Beveridge; Joseph Wong; Ajay Singh; Daniela Galimberti; Barbara Borroni; Xiongwei Zhu; Janis Blevins; Justin Greenlee; George Perry; Chinmay K Mukhopadhyay; Christine Schmotzer; Neena Singh
Journal:  Antioxid Redox Signal       Date:  2013-04-16       Impact factor: 8.401

Review 8.  Prions and prion diseases: Insights from the eye.

Authors:  Neena Singh; Suman Chaudhary; Ajay Ashok; Ewald Lindner
Journal:  Exp Eye Res       Date:  2020-08-25       Impact factor: 3.467

Review 9.  Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Matthew K McElwee; Katharine Horback; Amber Beserra
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

Review 10.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.